| Product Code: ETC7752023 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan mRNA Vaccine and Therapeutics Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Japan mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Japan mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Japan mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and funding for mRNA vaccine research and development in Japan |
4.2.2 Growing awareness and acceptance of mRNA technology in healthcare in Japan |
4.2.3 Rising prevalence of infectious diseases and chronic conditions driving the demand for mRNA vaccines and therapeutics in Japan |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA vaccine production and distribution in Japan |
4.3.2 Stringent regulatory approval processes for mRNA vaccines and therapeutics in Japan |
5 Japan mRNA Vaccine and Therapeutics Market Trends |
6 Japan mRNA Vaccine and Therapeutics Market, By Types |
6.1 Japan mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Japan mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Japan mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Japan mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Japan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Japan mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Japan mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Japan mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development investments in mRNA technology in Japan |
8.2 Number of clinical trials and approvals for mRNA vaccines and therapeutics in Japan |
8.3 Adoption rate of mRNA vaccines and therapeutics by healthcare providers in Japan |
9 Japan mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Japan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Japan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Japan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Japan mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Japan mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Japan mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here